The thick client is making a comeback. Here’s how next-generation local databases like PGlite and RxDB are bringing ...
Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Glimmers of a resurgence in biotech IPO activity in 2026 have continued with the news that two more companies – Belgium's AgomAb Therapeutics and SpyGlass Pharma of the US – are sizing up investor ...
Ascendis wins US approval for therapy for children with dwarfism The U.S. Food and Drug Administration on Friday approved Ascendis Pharma's once-weekly therapy for children with a rare genetic ...
Jesse and Shilpa answer listener questions and chat with iconic baker Cheryl Day.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results